Coronavirus Disease 2019 Infection as a Risk Factor for Infective Endocarditis

Dilesha Kumanayaka; Monica Mutyala; Dhinesh V Reddy; Jihad Slim

doi:10.7759/cureus.14813

Coronavirus Disease 2019 Infection as a Risk Factor for Infective Endocarditis

Cureus. 2021 May 3;13(5):e14813. doi: 10.7759/cureus.14813.

Authors

Dilesha Kumanayaka^{1

2}, Monica Mutyala^{3

2}, Dhinesh V Reddy^{1

2}, Jihad Slim^{3

2}

Affiliations

¹ Department of Internal Medicine, Saint Michael's Medical Center/New York Medical College, Newark, USA.
² Department of Medical Education, Saint Michael's Medical Center/New York Medical College, Newark, USA.
³ Department of Infectious Diseases, Saint Michael's Medical Center/New York Medical College, Newark, USA.

Abstract

Infective endocarditis (IE) is associated with relatively high morbidity and mortality and several risk factors have been identified in the past. Several predisposing factors for IE have been recognized in the literature, depending on the type of bacteria. Coronavirus disease 2019 (COVID-19) infection causes coagulopathy-associated complications and damage to many organ systems due to the inflammatory response induced by this viral infection. COVID-19 emerged only about a year ago and there are many unknown post-COVID-19 complications at this time. Here, we present the case of Streptococcus mitis IE in a patient with no prior predisposing factors other than diagnosis with COVID-19 a month ago.

Keywords: covid-19; covid-19 coagulopathy side effects; covid-19 endocarditis; cytokine storms; hypercoagulopathy; infective endocarditis; sars-cov-2 infection.

Publication types

Case Reports